Edition:
United States

Elekta AB (publ) (EKTAb.ST)

EKTAb.ST on Stockholm Stock Exchange

73.80SEK
21 Feb 2018
Change (% chg)

0.82kr (+1.12%)
Prev Close
72.98kr
Open
72.78kr
Day's High
74.18kr
Day's Low
72.56kr
Volume
1,333,712
Avg. Vol
1,453,341
52-wk High
95.90kr
52-wk Low
66.12kr

Select another date:

BRIEF-Bolivia buys linear accelerators from Elekta

* BOLIVIAN GOVERNMENT INVESTS IN STATE-OF-THE-ART CANCER CARE FROM ELEKTA

BRIEF-Elekta's Gamma Knife system cleared for use by China

* ELEKTA'S LEKSELL GAMMA KNIFE ICON RADIOSURGERY SYSTEM CLEARED FOR USE IN CHINA Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

BRIEF-Elekta signs $29 mln deal with the Ottawa Hospital

* THE OTTAWA HOSPITAL ACQUIRES SEVERAL ELEKTA VERSA HD DEVICES FOR ADVANCED CANCER TREATMENT

BRIEF-Elekta reaches agreement in dispute with Stockholm County Council

* ELEKTA AND STOCKHOLM COUNTY COUNCIL AGREE ON CONSTRUCTIVE WAY FORWARD

UPDATE 1-Elekta delays order target for new radiation therapy machine

STOCKHOLM, Nov 30 Sweden's Elekta pushed back its order target for a new radiation therapy machine which is meant to drive its future sales growth on Thursday as it reported higher quarterly core earnings than expected.

BRIEF-Elekta CEO: Unity radiation therapy system a 2018 sales driver

Nov 30 Elekta AB CEO Richard Hausmann and CFo Gustaf Salford in a conference call with analysts and media:

Elekta postpones order target for new flagship product Unity

STOCKHOLM, Nov 30 Swedish radiotherapy gear maker Elekta on Thursday pushed back its target for order bookings of its new flagship radiation therapy machine Unity as it posted higher quarterly core earnings, but lower order intake, than expected.

BRIEF-Elekta Q2 core profit beat expectations, orders lag

* SAYS ‍OUR TARGETS FOR YEAR ARE CLEAR - WE WILL DELIVER PROFITABLE GROWTH AND REACH AN EBITA MARGIN EXCEEDING 20 PERCENT THROUGH GROWTH AND OUR WORK WITH CONTINUOUS OPERATIONAL IMPROVEMENTS​

BRIEF-Elekta signs £22 mln agrement with UK's National Health Service

* UK'S NATIONAL HEALTH SERVICE SIGNS GBP 22 MILLION AGREEMENT FOR ELEKTA CANCER TREATMENT SYSTEMS

BRIEF-21St century oncology chooses Elekta for replacement of radiation therapy devices

* Elekta announces that 21st Century Oncology, the largest radiation oncology provider in the U.S., will replace several of its existing linear accelerators, as well as treatment planning software and oncology information systems, with advanced cancer treatment solutions from Elekta. Source text for Eikon: Further company coverage: (Reporting By Johan Ahlander)

Select another date: